Potentially inappropriate prescriptions and therapeutic complexity in older HIV patients with comorbidities.

Background: The prolonged current survival of human immunodeficiency virus (HIV) patients exposes them to new problems arising from the comorbidities they face.

Objectives: To describe the situation of comorbidities, polypharmacy, therapeutic complexity and adherence in people living with HIV over 65 years of age and to assess the presence of potentially inappropriate prescriptions (PIP) by applying deprescription criteria.

Methods: Observational study including HIV people (> 65 years) from a university tertiary level hospital.

Differences in survival according to malignancy type and degree of immunodeficiency in HIV-infected patients.

Background And Objective: After the introduction of antiretroviral therapy, a decrease in AIDS defining cancers (ADCs) is observed, while non-AIDS-defining cancers (NADCs) have increased in HIV-infected patients (HIP). We have little information about the prognosis and associated risk factors. We studied survival and its relationship with immunodeficiency after the diagnosis of ADC or NADC.

Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.

Background: The percentage of older HIV-positive patients is growing, with an increase in age-related comorbidities and concomitant medication.

Objectives: To quantify polypharmacy and profile types of non-antiretroviral drugs collected at community pharmacies in 2014 by HIV-positive individuals on antiretroviral therapy and to compare these findings with those of the general population.

Methods: HIV-positive patients (n=199) were compared with a group of patients from the general population (n=8,172), aged between 50 and 64 years.

Prevalence of concomitant medications in older HIV+ patients and comparison with general population.

Objective: The increasing population of human immunodeficiency virus (HIV)-infected elderly patients results in a higher number of comorbidities and greater incidence of polypharmacy in addition to antiretroviral therapy (ART). The aim of this study is to describe the use of concomitant medication in older HIV-infected patients and to compare it with older general population.

Methods: The study included HIV-positive outpatients (>49 years) who received ART in 2011.

Clinical characteristics and antiretroviral treatment of older HIV-infected patients.

Background: The number of Human Immunodeficiency Virus (HIV) patients aged 50 years or over is growing year on year, due to both late diagnoses and the chronicity of the illness. This increase is a new phenomenon.

Objective: To describe the clinical and epidemiological characteristics of the older HIV infected population and determine if there are differences in antiretroviral treatment between younger and older patients.